Sandra Gurrola
Förmögenhet: 27 $ per 2026-08-31
Förmögenhet: 27 $ per 2026-08-31
Sandra Gurrola worked as Senior Manager-Financial Reporting at Metabasis Therapeutics, Inc. from 2007 to 2009.
From 2009 to 2021, served as Secretary & Senior Vice President-Finance at NTN Buzztime, Inc. In 2021, held the position of Senior Vice President at eGames.com Holdings LLC.
From 2022 to 2023, worked as Principal Accounting Officer & VP-Finance at Ernexa Therapeutics, Inc. Completed undergraduate education at San Diego State University in 1991.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-07 | 6 ( 0 % ) | 27 $ | 2026-08-31 |
| Företag | Position | Slut |
|---|---|---|
| ERNEXA THERAPEUTICS INC. | Finansdirektör/CFO | 2026-07-03 |
eGames.com Holdings LLC
eGames.com Holdings LLC Packaged SoftwareTechnology Services Operates as a game publishing business | Finansdirektör/CFO | 2021-06-01 |
| NTN BUZZTIME, INC. | Finansdirektör/CFO | 2021-03-01 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
NTN Buzztime, Inc.
NTN Buzztime, Inc. Packaged SoftwareTechnology Services Develops and distributes TV games for restaurants and sports bars | Technology Services |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
eGames.com Holdings LLC
eGames.com Holdings LLC Packaged SoftwareTechnology Services Operates as a game publishing business | Technology Services |
Eterna Therapeutics, Inc.
Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån